Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry
暂无分享,去创建一个
A. Inchingolo | A. Patano | A. Inchingolo | G. Malcangi | A. Scarano | F. Lorusso | G. Dipalma | F. Inchingolo | B. Rapone | L. Bellocchio | Ciro Gargiulo Isacco | E. de Ruvo | A. Mancini | C. G. Isacco
[1] Lina Yu,et al. Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells , 2023, Biomolecules.
[2] J. Castellanos,et al. Immune challenges upregulate the expression of cannabinoid receptors in cultured human odontoblasts and gingival fibroblasts , 2022, Acta odontologica latinoamericana : AOL.
[3] R. Duarte,et al. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study , 2022, Journal of Cannabis Research.
[4] H. Bradshaw,et al. Cannabinoid CB1 receptors regulate salivation , 2022, Scientific Reports.
[5] M. Azizi,et al. Evaluation of cannabinoid receptors type 1–2 in periodontitis patients , 2022, Clinical and experimental dental research.
[6] K. Derefinko,et al. A critical review of cannabis in medicine and dentistry: A look back and the path forward , 2022, Clinical and experimental dental research.
[7] J. Vacek,et al. Cannabidiol and periodontal inflammatory disease: A critical assessment. , 2022, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[8] A. Inchingolo,et al. Cannabinoids Drugs and Oral Health—From Recreational Side-Effects to Medicinal Purposes: A Systematic Review , 2021, International journal of molecular sciences.
[9] J. Arnold,et al. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization , 2021, The AAPS Journal.
[10] C. Limebeer,et al. Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting. , 2021, Cannabis and cannabinoid research.
[11] Haipei Luan,et al. Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. , 2021, Journal of dentistry.
[12] Laureano Schofs,et al. The antimicrobial effect behind Cannabis sativa , 2021, Pharmacology research & perspectives.
[13] John F. Trant,et al. The biosynthesis of the cannabinoids , 2021, Journal of Cannabis Research.
[14] M. Silvestrini,et al. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome , 2021, CNS Drugs.
[15] A. Jones,et al. The Past, Present and Future of Cannabis sativa Tissue Culture , 2020, Plants.
[16] S. Paurazas,et al. Evaluation of Cannabinoids on the Odonto/osteogenesis in Human Dental Pulp Cells In Vitro. , 2020, Journal of endodontics.
[17] I. Berindan‐Neagoe,et al. Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells , 2020, Medicina.
[18] N. Toyang,et al. Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential , 2020, Plants.
[19] Yousef N. Alharbi. Current legal status of medical marijuana and cannabidiol in the United States , 2020, Epilepsy & Behavior.
[20] M. Crocq. History of cannabis and the endocannabinoid system , 2020, Dialogues in clinical neuroscience.
[21] H. Clarke,et al. Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence , 2020, Molecules.
[22] Jayme L. Dahlin,et al. The Essential Medicinal Chemistry of Cannabidiol (CBD). , 2020, Journal of medicinal chemistry.
[23] S. Daunert,et al. Cannabidiol as a Novel Therapeutic for Immune Modulation , 2020, ImmunoTargets and therapy.
[24] Dennis J Sholler,et al. Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies , 2020, Current Addiction Reports.
[25] I. Koturbash,et al. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway , 2020, Journal of dietary supplements.
[26] Y. Gabet,et al. The Cannabinoids Effect on Bone Formation and Bone Healing , 2020, Current Osteoporosis Reports.
[27] B. Møller,et al. Phytocannabinoids: Origins and Biosynthesis. , 2020, Trends in plant science.
[28] T. Dick,et al. Phytotherapy in Dentistry: A Literature Review Based on Clinical Data , 2020 .
[29] R. Moraes,et al. Cannabidiol in Dentistry: A Scoping Review , 2020, Dentistry journal.
[30] F. Guimarães,et al. Cannabidiol on 5-FU-induced oral mucositis in mice. , 2020, Oral diseases.
[31] N. Seeram,et al. Inhibitory Effect of Cannabidiol on the Activation of NLRP3 Inflammasome Is Associated with Its Modulation of the P2X7 Receptor in Human Monocytes. , 2020, Journal of natural products.
[32] V. Stahl,et al. Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation , 2020, Cureus.
[33] M. Haque,et al. Preparation of Medicinal Plants: Basic Extraction and Fractionation Procedures for Experimental Purposes , 2020, Journal of pharmacy & bioallied sciences.
[34] S. Atalay,et al. Antioxidative and Anti-Inflammatory Properties of Cannabidiol , 2019, Antioxidants.
[35] Haiyan Lu,et al. Activation of Cannabinoid Receptors Promote Periodontal Cell Adhesion and Migration. , 2019, Journal of clinical periodontology.
[36] P. Yates,et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) , 2019, BMC Palliative Care.
[37] R. Lamont,et al. Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens , 2019, Front. Immunol..
[38] A. Kamali,et al. Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects. , 2019, Materials science & engineering. C, Materials for biological applications.
[39] Debopam Samanta. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. , 2019, Pediatric neurology.
[40] H. Duncan,et al. European Society of Endodontology position statement: Management of deep caries and the exposed pulp. , 2019, International endodontic journal.
[41] M. Lefsrud,et al. An Update on Plant Photobiology and Implications for Cannabis Production , 2019, Front. Plant Sci..
[42] M. R. Iyer,et al. Crystal Structure of the Human Cannabinoid Receptor CB2 , 2019, Cell.
[43] M. Baciut,et al. Cannabinoids and bone regeneration , 2019, Drug metabolism reviews.
[44] R. Franco,et al. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1‐CB2 heteroreceptor complexes , 2018, Biochemical pharmacology.
[45] K. Mackie,et al. Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D , 2018, Cannabis and cannabinoid research.
[46] P. Ruben,et al. Inhibitory effects of cannabidiol on voltage-dependent sodium currents , 2018, The Journal of Biological Chemistry.
[47] M. Alaverdashvili,et al. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors , 2018, British journal of pharmacology.
[48] F. Guimarães,et al. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation , 2018, Phytotherapy research : PTR.
[49] E. Mazzon,et al. Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway , 2018, International journal of molecular sciences.
[50] E. Ovidi,et al. Natural products for human health: an historical overview of the drug discovery approaches , 2018, Natural product research.
[51] B. Malinowska,et al. Enhanced endocannabinoid tone as a potential target of pharmacotherapy , 2018, Life sciences.
[52] Z. Song,et al. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol , 2018, Acta Pharmacologica Sinica.
[53] M. Maranesi,et al. The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular gland: The influence of different physical forms of diets on their expression in piglets , 2018, Journal of animal physiology and animal nutrition.
[54] N. Teixeira,et al. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis , 2018, Journal of Physiology and Biochemistry.
[55] Julen Oyarzabal,et al. Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors , 2017, Front. Pharmacol..
[56] H. Kondo,et al. Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol. , 2017, Archives of oral biology.
[57] A. Malfitano,et al. Cannabidiol: State of the art and new challenges for therapeutic applications. , 2017, Pharmacology & therapeutics.
[58] F. Grotenhermen,et al. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies , 2017, Cannabis and cannabinoid research.
[59] I. McGregor,et al. The direct actions of cannabidiol and 2‐arachidonoyl glycerol at GABAA receptors , 2017, Pharmacological research.
[60] M. L. de la Casa,et al. Evaluation of pH and calcium ion diffusion from calcium hydroxide pastes and MTA. , 2017, Acta odontologica latinoamericana : AOL.
[61] P. Brossart,et al. In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local Pathophysiology , 2017, Cellular and Molecular Neurobiology.
[62] E. Piva,et al. Could the application of bioactive molecules improve vital pulp therapy success? A systematic review. , 2017, Journal of biomedical materials research. Part A.
[63] M. Bifulco,et al. Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back. , 2017, Trends in pharmacological sciences.
[64] M. A. Figueiredo,et al. Cannabidiol: an alternative therapeutic agent for oral mucositis? , 2017, Journal of clinical pharmacy and therapeutics.
[65] F. Wang,et al. Expression of Cannabinoid Type 1 Receptors in Human Odontoblast Cells , 2017, Journal of endodontics.
[66] E. Mazzon,et al. Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells , 2016, Front. Physiol..
[67] J. Cherney,et al. Industrial Hemp in North America: Production, Politics and Potential , 2016 .
[68] R. Stevens,et al. Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.
[69] M. Ashley,et al. Cannabis: A joint problem for patients and the dental profession , 2016, BDJ.
[70] J. Elverdín,et al. Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist HU-308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis. , 2016, Journal of periodontology.
[71] J. Klijanienko,et al. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival , 2016, Tumor Biology.
[72] M. Nagarkatti,et al. Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo , 2015, The Journal of Immunology.
[73] Joseph M Pappachan,et al. Diabetes mellitus and oral health , 2015, Endocrine.
[74] S. Burstein. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. , 2015, Bioorganic & medicinal chemistry.
[75] D. Deutsch,et al. Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)* , 2015, The Journal of Biological Chemistry.
[76] V. Marzo,et al. Endocannabinoid signalling and the deteriorating brain , 2014, Nature Reviews Neuroscience.
[77] Namrata Singh,et al. Cannabinoid-induced changes in respiration of brain mitochondria. , 2014, Toxicology letters.
[78] C. Fowler,et al. Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[79] R. Mechoulam,et al. Early phytocannabinoid chemistry to endocannabinoids and beyond , 2014, Nature Reviews Neuroscience.
[80] E. Murillo-Rodríguez,et al. Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats , 2014, Neuroscience Research.
[81] A. Padovani,et al. Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis. , 2014, Histology and histopathology.
[82] R. Ramer,et al. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK. , 2014, Biochemical pharmacology.
[83] Z. Vogel,et al. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death , 2013, Cell Death and Disease.
[84] B. Sadek,et al. Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. , 2013, European journal of pharmacology.
[85] L. Mestre,et al. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors , 2013, Neurobiology of Disease.
[86] D. Geschwind,et al. Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells , 2013, PloS one.
[87] M. Elphick. The evolution and comparative neurobiology of endocannabinoid signalling , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.
[88] Y. Sahara,et al. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts. , 2012, Cell calcium.
[89] Joshua R. Smith,et al. Harnessing the natural regenerative potential of the dental pulp. , 2012, Dental clinics of North America.
[90] D. Tipton,et al. Effect of cannabidiol on human gingival fibroblast extracellular matrix metabolism: MMP production and activity, and production of fibronectin and transforming growth factor β. , 2012, Journal of periodontal research.
[91] M. Torii,et al. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture. , 2012, Journal of endodontics.
[92] P. Fletcher,et al. Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus , 2012, British journal of pharmacology.
[93] L. Ford,et al. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro , 2012, British journal of pharmacology.
[94] M. Hellmich,et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia , 2012, Translational Psychiatry.
[95] T. Bisogno,et al. Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes , 2011, British journal of pharmacology.
[96] M. Borges,et al. Oral and maxillofacial trauma in patients with epilepsy: prospective study based on an outpatient population. , 2011, Arquivos de neuro-psiquiatria.
[97] P. Anand,et al. Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp , 2010, Journal of Clinical Neuroscience.
[98] M. Maccarrone,et al. GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor. , 2010, Current medicinal chemistry.
[99] T. Shippenberg,et al. The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes , 2010, Journal of Pharmacology and Experimental Therapeutics.
[100] I. Maruyama,et al. Involvement of the endocannabinoid system in periodontal healing. , 2010, Biochemical and biophysical research communications.
[101] R. Margolskee,et al. Endocannabinoids selectively enhance sweet taste , 2009, Proceedings of the National Academy of Sciences.
[102] Z. Vogel,et al. Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells* , 2009, The Journal of Biological Chemistry.
[103] Wayne Hall,et al. Adverse health effects of non-medical cannabis use , 2009, The Lancet.
[104] K. Mackie,et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo , 2009, Proceedings of the National Academy of Sciences.
[105] V. Rettori,et al. Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion. , 2009, Alcohol and alcoholism.
[106] G. Godlewski,et al. Receptors for acylethanolamides-GPR55 and GPR119. , 2009, Prostaglandins & other lipid mediators.
[107] I. Yamamoto,et al. Cannabidiol-2′,6′-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor , 2009, Drug Metabolism and Disposition.
[108] D. Fuchs,et al. Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro , 2009, Journal of Neuroimmunology.
[109] M. Karst,et al. The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function , 2009, Pharmacology.
[110] F. Guimarães,et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. , 2009, International immunopharmacology.
[111] M. Holland,et al. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). , 2008, European journal of pharmacology.
[112] V. Marzo. The endocannabinoid system in obesity and type 2 diabetes , 2008, Diabetologia.
[113] T. Hutchinson,et al. TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons , 2008, The Journal of Neuroscience.
[114] M. Connor,et al. Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol* , 2008, Journal of Biological Chemistry.
[115] V. Vellani,et al. Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8 , 2008, Journal of Pharmacology and Experimental Therapeutics.
[116] C. Reynet,et al. GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity , 2008, British journal of pharmacology.
[117] K. Mackie,et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.
[118] S. Hjorth,et al. The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.
[119] Ethan B. Russo. History of Cannabis and Its Preparations in Saga, Science, and Sobriquet , 2007, Chemistry & biodiversity.
[120] Didier Bagnol,et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. , 2007, Endocrinology.
[121] R. Pertwee,et al. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro , 2007, British journal of pharmacology.
[122] P. Pacher,et al. The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.
[123] S. Mccann,et al. Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors , 2006, Experimental biology and medicine.
[124] H. Korf,et al. Cannabinoids attenuate norepinephrine‐induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N‐acetyltransferase activity without involvement of cannabinoid receptors , 2006, Journal of neurochemistry.
[125] C. Hillard,et al. Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[126] Y. Izumi,et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF‐κB pathway inhibition , 2006, FEBS letters.
[127] M. Zeira,et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice , 2006, Autoimmunity.
[128] E. Russo,et al. Agonistic Properties of Cannabidiol at 5-HT1a Receptors , 2005, Neurochemical Research.
[129] K. Naruse,et al. Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. , 2005, Life sciences.
[130] I. Yamamoto,et al. Marijuana extracts possess the effects like the endocrine disrupting chemicals. , 2005, Toxicology.
[131] B. Costa,et al. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation , 2004, British journal of pharmacology.
[132] K. Rosenblatt,et al. Marijuana Use and Risk of Oral Squamous Cell Carcinoma , 2004, Cancer Research.
[133] D. Piomelli. The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.
[134] A. Finazzi-Agro’,et al. The Endocannabinoid System in Human Keratinocytes , 2003, Journal of Biological Chemistry.
[135] M. Herkenham,et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.
[136] D. Ponde,et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide , 2001, British journal of pharmacology.
[137] R. Mechoulam,et al. A historical overview of chemical research on cannabinoids. , 2000, Chemistry and physics of lipids.
[138] M. Feldmann,et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[139] L. Petrocellis,et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action , 1998, Trends in Neurosciences.
[140] K. Mackie,et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.
[141] Z. Vogel,et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.
[142] S. Munro,et al. Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.
[143] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[144] T. Bonner,et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.
[145] A. Howlett,et al. Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.
[146] F. Evans,et al. Activation of phospholipase A2 by cannabinoids , 1987, FEBS letters.
[147] A. Howlett,et al. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. , 1984, Molecular pharmacology.
[148] R. Branconnier,et al. Cannabis: effects on memory and the cholinergic limbic system. , 1983, Psychological bulletin.
[149] S. R. Gilman,et al. Cannabinoids Impair the Formation of Cholesteryl Ester in Cultured Human Cells , 1981, Arteriosclerosis.
[150] G. Sharma,et al. Constituents of Cannabis sativa , 1979 .
[151] R. Pertwee,et al. EFFECTS OF Δ9‐TETRAHYDROCANNABINOL AND CANNABIDIOL ON A Mg2+‐ATPase OF SYNAPTIC VESICLES PREPARED FROM RAT CEREBRAL CORTEX , 1977 .
[152] F. Bazzaz,et al. Photosynthesis and cannabinoid content of temperate and tropical populations of Cannabis sativa , 1975 .
[153] E. R. Garrett,et al. Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol , 1974 .
[154] R. Mechoulam,et al. Chemical Basis of Hashish Activity , 1970, Science.
[155] R. Mechoulam,et al. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .
[156] R. Adams. Marihuana: Harvey Lecture, February 19, 1942. , 1942, Bulletin of the New York Academy of Medicine.
[157] V. Stahl. Cannabis and derivatives thereof for the treatment of pain and inflammation related with dental pulp and bone regeneration related to dental jaw bone defects , 2018 .
[158] A. Howlett,et al. CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.
[159] G. Santoni,et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. , 2013, Carcinogenesis.
[160] B. Klingeren,et al. Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol , 2004, Antonie van Leeuwenhoek.
[161] R. Adams,et al. Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I , 1940 .